tiprankstipranks
Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO
US Market

Soleno Therapeutics (SLNO) Income Statement

Compare
728 Followers

Soleno Therapeutics Income Statement

Last quarter (Q3 2024), Soleno Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Soleno Therapeutics's net income was $-76.62M. See Soleno Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.96M$ -2.21M$ -2.21M$ -2.19M$ -2.30M
Operating Expenses
$ 41.38M$ 25.11M$ 32.26M$ 31.95M$ 23.20M
Depreciation and Amortization
$ 1.96M$ 2.21M$ 2.21M$ 2.19M$ 2.30M
EBITDA
$ -37.03M$ -21.86M$ -28.70M$ -30.00M$ -28.48M
Operating Income
$ -41.38M$ -24.40M$ -31.53M$ -36.29M$ -23.49M
Other Income/Expenses
$ 2.40M$ 330.00K$ 618.00K$ 11.65M$ -7.29M
Pretax Income
$ -38.99M$ -24.07M$ -30.91M$ -24.64M$ -30.77M
Net Income
$ -38.99M$ -20.32M$ -29.56M$ -15.38M$ -35.91M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.36$ -2.42$ -5.56$ -3.68$ -15.78
Diluted EPS
$ -2.36$ -2.42$ -5.56$ -3.68$ -15.78
Weighted Average Shares Outstanding
16.49M 8.40M 5.32M 4.17M 2.28M
Weighted Average Shares Outstanding (Diluted)
16.49M 8.40M 5.32M 4.17M 2.28M
Currency in USD

Soleno Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis